These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 15704197
1. Stereoselective pharmacokinetics of RS-8359, a selective and reversible MAO-A inhibitor, by species-dependent drug-metabolizing enzymes. Takasaki W, Yamamura M, Nozaki A, Nitanai T, Sasahara K, Itoh K, Tanaka Y. Chirality; 2005 Mar; 17(3):135-41. PubMed ID: 15704197 [Abstract] [Full Text] [Related]
2. Enantioselective 2-hydroxylation of RS-8359, a selective and reversible MAO-A inhibitor, by cytochrome P450 in mouse and rat liver microsomes. Itoh K, Nishiya Y, Takasaki W, Adachi M, Tanaka Y. Chirality; 2006 Aug; 18(8):592-8. PubMed ID: 16642492 [Abstract] [Full Text] [Related]
3. Stereoselective pharmacokinetics of RS-8359, a selective and reversible inhibitor of A-type monoamine oxidase, in rats, mice, dogs, and monkeys. Takasaki W, Yamamura M, Shigehara E, Suzuki Y, Tonohiro T, Hara T, Tanaka Y. Biol Pharm Bull; 1999 May; 22(5):498-503. PubMed ID: 10375171 [Abstract] [Full Text] [Related]
4. Species differences in enantioselective 2-oxidations of RS-8359, a selective and reversible MAO-A inhibitor, and cinchona alkaloids by aldehyde oxidase. Itoh K, Yamamura M, Takasaki W, Sasaki T, Masubuchi A, Tanaka Y. Biopharm Drug Dispos; 2006 Apr; 27(3):133-9. PubMed ID: 16400710 [Abstract] [Full Text] [Related]
5. Chiral inversion of RS-8359: a selective and reversible MAO-A inhibitor via oxido-reduction of keto-alcohol. Itoh K, Hoshino K, Endo A, Asakawa T, Yamakami K, Noji C, Kosaka T, Tanaka Y. Chirality; 2006 Sep; 18(9):698-706. PubMed ID: 16823812 [Abstract] [Full Text] [Related]
6. Stereoselective pharmacokinetics of flobufen in rats. Trejtnar F, Wsol V, Szotakova B, Skalova L, Pavek P, Kuchar M. Chirality; 1999 Sep; 11(10):781-6. PubMed ID: 10561708 [Abstract] [Full Text] [Related]
7. Species differences in the formation of DA-8164 after intravenous and/or oral administration of DA-8159, a new erectogenic, to mice, rats, rabbits, dogs and humans. Shim HJ, Kim YC, Lee JH, Park KJ, Kwon JW, Kim WB, Lee MG. Biopharm Drug Dispos; 2005 May; 26(4):161-6. PubMed ID: 15803515 [Abstract] [Full Text] [Related]
8. Stereoselective pharmacokinetics of clausenamide enantiomers and their major metabolites after single intravenous and oral administration to rats. Zhu CJ, Zhang JT. Chirality; 2003 Oct; 15(8):668-73. PubMed ID: 12923804 [Abstract] [Full Text] [Related]
9. Interspecies pharmacokinetic scaling of DA-8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics. Shim HJ, Kim YC, Lee JH, Kwon JW, Kim WB, Kim YG, Kim SH, Lee MG. Biopharm Drug Dispos; 2005 Oct; 26(7):269-77. PubMed ID: 15991256 [Abstract] [Full Text] [Related]
10. Rat strain differences in stereospecific 2-oxidation of RS-8359, a reversible and selective MAO-A inhibitor, by aldehyde oxidase. Sasaki T, Masubuchi A, Yamamura M, Watanabe N, Hiratsuka M, Mizugaki M, Itoh K, Tanaka Y. Biopharm Drug Dispos; 2006 Jul; 27(5):247-55. PubMed ID: 16586463 [Abstract] [Full Text] [Related]
11. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 3rd communication: plasma concentrations of the unchanged drug and its deethylated metabolite in rats, dogs and monkeys. Nakamura A, Hirota T, Sugihara K, Morino A. Arzneimittelforschung; 1997 Feb; 47(2):169-74. PubMed ID: 9079236 [Abstract] [Full Text] [Related]
12. Species-related stereoselective disposition of ofloxacin in the rat, dog and monkey. Okazaki O, Kurata T, Hakusui H, Tachizawa H. Xenobiotica; 1992 Apr; 22(4):439-50. PubMed ID: 1523865 [Abstract] [Full Text] [Related]
13. Enantiomer-selective pharmacokinetics and metabolism of ketorolac in children. Kauffman RE, Lieh-Lai MW, Uy HG, Aravind MK. Clin Pharmacol Ther; 1999 Apr; 65(4):382-8. PubMed ID: 10223774 [Abstract] [Full Text] [Related]
14. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics. Bae SK, Lee SJ, Kim YG, Kim SH, Kim JW, Kim T, Lee MG. Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427 [Abstract] [Full Text] [Related]
15. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog. Cook CS, Karim A, Sollman P. Drug Metab Dispos; 1982 Apr; 10(2):116-21. PubMed ID: 6124395 [Abstract] [Full Text] [Related]
16. Species-dependent stereopharmacokinetics of MK-927, a potent carbonic anhydrase inhibitor. Lin JH, Chen IW, Lin TH. Drug Metab Dispos; 1991 Apr; 19(4):816-22. PubMed ID: 1680660 [Abstract] [Full Text] [Related]
17. Stereoselective pharmacokinetics of tetrahydropalmatine after oral administration of (-)-enantiomer and the racemate. Hong Z, Fan G, Chai Y, Yin X, Wu Y. Chirality; 2005 May 15; 17(5):293-6. PubMed ID: 15846827 [Abstract] [Full Text] [Related]
18. Pharmacokinetics of reboxetine enantiomers in the dog. Frigerio E, Benecchi A, Brianceschi G, Pellizzoni C, Poggesi I, Strolin Benedetti M, Dostert P. Chirality; 1997 May 15; 9(3):303-6. PubMed ID: 9176997 [Abstract] [Full Text] [Related]
19. Stereospecific oxidation of the (S)-enantiomer of RS-8359, a selective and reversible monoamine oxidase A (MAO-A) inhibitor, by aldehyde oxidase. Itoh K, Yamamura M, Muramatsu S, Hoshino K, Masubuchi A, Sasaki T, Tanaka Y. Xenobiotica; 2005 Jun 15; 35(6):561-73. PubMed ID: 16192108 [Abstract] [Full Text] [Related]
20. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Species comparison and allometric scaling. Feng MR, Loo J, Wright J. Drug Metab Dispos; 1998 Oct 15; 26(10):982-8. PubMed ID: 9763403 [Abstract] [Full Text] [Related] Page: [Next] [New Search]